GelStat Corp. Announces Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for 2015
The company generated consolidated revenue in excess of $1.3 million for the full year ended December 31, 2014 led by its wholly owned subsidiary Mastix Medica.
For 2015, the company expects growth to continue and revenues to be in the $4.5 to $5.5 million range.